StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Regentis Biomaterials's total debt was $1.20M at Dec 31, 2025. For fiscal 2025 it was $1.20M, up 108.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.20M+108.9%
FY2024Dec 31, 2024$573.00K+172.9%
FY2023Dec 31, 2023$210.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$1.20M–
Q4 FY2024Dec 31, 2024$573.00K–
Q4 FY2023Dec 31, 2023$210.00K–

More Regentis Biomaterials figures

See a number that looks wrong?